Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ignacio Maureira"'
Autor:
Camilo Tapia-Valladares, Guillermo Valenzuela, Evelin González, Ignacio Maureira, Jessica Toro, Matías Freire, Gonzalo Sepúlveda-Hermosilla, Diego Ampuero, Alejandro Blanco, Iván Gallegos, Fernanda Morales, José I. Erices, Olga Barajas, Mónica Ahumada, Héctor R. Contreras, Jaime González, Ricardo Armisén, Katherine Marcelain
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 9, p 4695 (2024)
Colorectal cancer (CRC) is the second leading cause of cancer deaths globally. While ethnic differences in driver gene mutations have been documented, the South American population remains understudied at the genomic level, despite facing a rising bu
Externí odkaz:
https://doaj.org/article/956dc6976f554e7ca601afb0e64c2e5e
Publikováno v:
Mineralium Deposita. 58:379-402
Publikováno v:
Boletín Científico Sapiens Research, Vol 5, Iss 2, Pp 8-12 (2015)
La muerte es un fenómeno complejo que forma parte de la existencia y ha sido pensado desde tiempos remotos. En ese sentido, se han propuesto distintas actitudes ante la muerte a partir del aporte de disciplinas como el psicoanálisis, la filosofía
Externí odkaz:
https://doaj.org/article/6fec0cb39aaf4a2e9abe426ad6f90f49
Autor:
Eva Bustamante, Nicolás Miranda-González, Alicia Colombo, Monica Ahumada, María Loreto Bravo, Justo Lorenzo Bermejo, Katherine Marcelain, Ignacio Maureira, Erik Morales, Lorena Gutiérrez, Verónica Sanhueza, Gonzalo de Toro, Jessica Toro, Evelin González-Feliú, Carolina Ibañez, Ricardo A. Verdugo, Ricardo Armisen, Iván Gallegos, Carolina Bizama, M. Loreto Spencer, Patricia García, Mauricio Salvo, Camilo Villamán, Olga Barajas, Ana María Carrasco
Publikováno v:
Journal of Personalized Medicine
Volume 11
Issue 9
Journal of Personalized Medicine, Vol 11, Iss 899, p 899 (2021)
Volume 11
Issue 9
Journal of Personalized Medicine, Vol 11, Iss 899, p 899 (2021)
Next-generation sequencing (NGS) is progressively being used in clinical practice. However, several barriers preclude using this technology for precision oncology in most Latin American countries. To overcome some of these barriers, we have designed